Precision NanoSystem

About:

Precision NanoSystem provides Neuro9Kit for the study of gene function in neurons and glia cells.

Website: http://www.precisionnanosystems.com/

Top Investors: BDC Venture Capital, Government of Canada, 5AM Ventures, Rising Tide, Northview LifeSciences

Description:

Precision Nanosystems develops tools and processes for the development and manufacture of nanoparticles for use as medicines and in medical research. It offers NanoAssemblr benchtop instrument for prototyping of nanoparticles, as well as for the development of nanoparticle-based drugs delivering RNA, small-molecule, and protein therapeutics. The company also provides Neuro9Kit for the study of gene function in neurons and glial cells, as well as potent delivery to primary cells; Test9Kit for the study of gene function in various cell types; and Hepato9Kit for the study of gene function in the liver. In addition, it provides instruments, reagents, and services to the life sciences researchers.

Total Funding Amount:

$37.6M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Vancouver, British Columbia, Canada

Founded Date:

2010-01-01

Founders:

James Taylor

Number of Employees:

11-50

Last Funding Date:

2020-10-23

IPO Status:

Private

Industries: